$5.20
-0.38-6.81%
In chiusura: -
$5.40
0.203.85%
After hour: Nov 7, 7:45 PM EDT
Galectin Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Galectin Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
GALT | Galectin Therapeutics | -$0.18 | -$0.11 | — | — | $0.00 | — | — | — | 11/21/2025 | |
GALT | Galectin Therapeutics | -$0.20 | -$0.16 | -$0.12 | 25.00% | $0.00 | — | $0.00 | — | 08/14/2025 | |
GALT | Galectin Therapeutics | -$0.19 | — | -$0.15 | — | $0.00 | — | $0.00 | — | 05/15/2025 | |
GALT | Galectin Therapeutics | -$0.16 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | 03/31/2025 | |
GALT | Galectin Therapeutics | -$0.24 | -$0.20 | -$0.18 | 10.00% | $0.00 | — | $0.00 | — | 11/13/2024 | |
GALT | Galectin Therapeutics | -$0.15 | -$0.16 | -$0.20 | -25.00% | $0.00 | — | $0.00 | — | 08/13/2024 | |
GALT | Galectin Therapeutics | -$0.19 | -$0.16 | -$0.19 | -18.75% | $0.00 | — | $0.00 | — | 05/15/2024 | |
GALT | Galectin Therapeutics | -$0.18 | -$0.16 | -$0.16 | 0.00% | $0.00 | — | $0.00 | — | 03/29/2024 | |
GALT | Galectin Therapeutics | -$0.14 | -$0.16 | -$0.24 | -50.00% | $0.00 | — | $0.00 | — | 11/13/2023 | |
GALT | Galectin Therapeutics | -$0.16 | -$0.21 | -$0.15 | 28.57% | $0.00 | — | $0.00 | — | 08/14/2023 | |
GALT | Galectin Therapeutics | -$0.17 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | 05/15/2023 | |
GALT | Galectin Therapeutics | -$0.12 | -$0.17 | -$0.18 | -5.88% | $0.00 | — | $0.00 | — | 03/30/2023 | |
GALT | Galectin Therapeutics | -$0.14 | -$0.20 | -$0.14 | 30.00% | $0.00 | — | $0.00 | — | 11/14/2022 | |
GALT | Galectin Therapeutics | -$0.15 | -$0.21 | -$0.16 | 23.81% | $0.00 | — | $0.00 | — | 08/15/2022 | |
GALT | Galectin Therapeutics | -$0.11 | -$0.14 | -$0.17 | -21.43% | $0.00 | — | $0.00 | — | 05/16/2022 | |
GALT | Galectin Therapeutics | -$0.13 | -$0.19 | -$0.12 | 36.84% | $0.00 | — | $0.00 | — | 03/31/2022 | |
GALT | Galectin Therapeutics | -$0.10 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | 11/15/2021 | |
GALT | Galectin Therapeutics | -$0.11 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | 08/16/2021 | |
GALT | Galectin Therapeutics | -$0.06 | -$0.17 | -$0.11 | 35.29% | $0.00 | — | $0.00 | — | 05/17/2021 | |
GALT | Galectin Therapeutics | -$0.12 | -$0.17 | -$0.13 | 23.53% | $0.00 | — | $0.00 | — | 03/31/2021 | |
GALT | Galectin Therapeutics | -$0.05 | -$0.14 | -$0.10 | 28.57% | $0.00 | — | $0.00 | — | 11/09/2020 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.12 | $-0.16 | 25.0 % |
| Q4 | 2025-03-31 | $-0.19 | $-0.21 | 9.52 % |
| Q3 | 2024-11-13 | $-0.18 | $-0.20 | 10.0 % |
| Q2 | 2024-08-13 | $-0.20 | $-0.16 | -25.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che Galectin Therapeutics (GALT) fornisca risultati il novembre 21, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.12, che superato la stima di $-0.16.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.